REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)
Condition: Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Intervention: Drug: chlormethine gel Sponsor: European Organisation for Research and Treatment of Cancer - EORTC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2020 Category: Research Source Type: clinical trials
REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)
Condition: Early Stage MF-CTCL (Stage IA-IB) Intervention: Drug: chlormethine gel Sponsor: European Organisation for Research and Treatment of Cancer - EORTC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2020 Category: Research Source Type: clinical trials
REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)
Condition: Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Intervention: Drug: chlormethine gel Sponsor: European Organisation for Research and Treatment of Cancer - EORTC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2020 Category: Research Source Type: clinical trials